Home › Research › Topics › donepezil-rivastigmine
donepezil-rivastigmine
2 studies tagged donepezil-rivastigmine, dated 2006-01-01 to 2013-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease 2013-01-01
- A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease 2006-01-01
Studies
2 studies carry this tag.
Date range
2006 to 2013
Top journals
- International journal of geriatric psychiatry 1
- Journal of Alzheimer's disease : JAD 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The modest beneficial effects of anti-dementia drugs on cognition are independent from dementia severity.
-
The cholinesterase inhibitors donepezil, rivastigmine, and galantamine can delay cognitive impairment in patients with mild to moderately-severe AD for at least 6 months duration.